Serological tests are blood tests conducted to detect and measure the concentration of antibodies against particular bacteria, virus, and any other foreign particle. Serological tests are widely used for the diagnosis of different types of bacterial, fungal, as well as viral infections. These tests have wide applications in diagnostic laboratories for the detection of infectious diseases, blood group typing, and diagnosis of autoimmune disorders. Different types of serological tests and techniques such as immunoassay tests, agglutination tests, and precipitation tests are available for the diagnosis of various disease conditions.
The global Serological Testing Market is projected to be driven by high prevalence and rise in incidence rates of acute as well as infectious diseases such as hepatitis, tuberculosis, and HIV/AIDS across the world. According to statistical data published by hiv.gov, around 36.7 million people were living with HIV/AIDS across the globe in 2016. Moreover, the prevalence of hepatitis C infection was estimated to be around 71 million globally in 2017. New product development and approvals for serological tests for a variety of bacterial and viral infections are likely to drive the global serological testing market during the forecast period. However, high cost of serological tests and stringent government regulations are expected to hamper the growth of the global market during the forecast period.
Request to View Brochure of Report –
The global serological testing market can be segmented based on type of serological test, application, end-user, and region. In terms of type of serological test, the global serological testing market can be classified into primary serological tests, secondary serological tests, and tertiary binding tests. The primary serological tests segment can be categorized based on marker techniques into enzyme linked immunosorbent assay (ELISA), immunoflurescent antibody technique (IFAT), and radio immunoassay (RIA).
The secondary serological tests segment can be divided into agglutination tests, complement fixation tests (CFT), precipitation tests, serum neutralization tests (SNT), and toxin-antitoxin tests. The primary serological tests segment is projected to dominate the global serological testing market during the forecast period. In terms of application, the global serological testing market can be segmented into rotavirus infections, hepatitis, HIV, endotoxins, therapeutic drug monitoring, and other infectious diseases. The hepatitis segment is anticipated to expand at the highest CAGR during the forecast period. Based on end-user, the global serological testing market can be classified into hospitals, diagnostic laboratories, blood banks, academic & research institutes, and others.
Request to View ToC of the report –
The global serological testing market is highly fragmented, with large number of manufacturers holding prominent share in respective regions. Key players operating in the global serological testing market include Serological Research Institute (SERI), Chembio Diagnostic Systems, Inc., Advanced Diagnostics, Inc., Randox Laboratories Ltd., Eurofins Scientific, Becton, Dickinson and Company, Quest Diagnostics, ELITechGroup, Immucor, Thermo Fisher Scientific, Inc., Beckman Coulter, Inc. (subsidiary of Danaher Corporation), Creative Diagnostics, and Grifols.